Avadel Pharmaceuticals ADRs Rise 19% on 3Q Revenue Growth of Lumryz Sales
By Denny Jacob American depositary receipts of Avadel Pharmaceuticals rose 19% to $12.34 on revenue growth powered by sales of Lumryz in the third quarter....
Source: marketwatch.com